Therapeutic Effect of a Novel Chimeric Molecule Targeting Both Somatostatin and Dopamine Receptors on Growth Hormone-Secreting Pituitary Adenomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic Effect of a Novel Chimeric Molecule Targeting Both Somatostatin and Dopamine Receptors on Growth Hormone-Secreting Pituitary Adenomas

Published:2020 Issue:1 Volume:35 Page:177
ISSN:2093-596X
Container-title:Endocrinology and Metabolism
language:en
Short-container-title:Endocrinol Metab

Author:

Kim Jean¹²^ORCID,Oh Ju Hun¹²^ORCID,Harlem Heather³,Culler Michael D.³,Ku Cheol Ryong²^ORCID,Lee Eun Jig¹²^ORCID

Affiliation:

1. Brain Korea 21 PLUS Project for Medical Science, Yonsei University, Seoul, Korea.

2. Endocrinology, Institute of Endocrine Research, Yonsei University College of Medicine, Seoul, Korea.

3. Endocrinology Research, Ipsen Bioscience Inc., Cambridge, MA, USA.

Funder

Ministry of Health and Welfare

National Research Foundation of Korea

Publisher

Korean Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://synapse.koreamed.org/pdf/10.3803/EnM.2020.35.1.177

Reference20 articles.

1. Acromegaly: An Endocrine Society Clinical Practice Guideline

2. Guidelines for Acromegaly Management: An Update

3. Somatostatin analogs: does pharmacology impact antitumor efficacy?

4. Expression of Somatostatin and Dopamine 2 Receptors in Neuroendocrine Tumours and the Potential Role for New Biotherapies

5. The role of somatostatin and dopamine D2 receptors in endocrine tumors

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pituitary Tumorigenesis—Implications for Management;Medicina;2023-04-21

2. Current and Emerging Medical Therapies in Pituitary Tumors;Journal of Clinical Medicine;2022-02-12

3. Characterization of the ability of a, second-generation SST-DA chimeric molecule, TBR-065, to suppress GH secretion from human GH-secreting adenoma cells;Pituitary;2021-01-12

4. Efficacy of a Novel Second-Generation Somatostatin-Dopamine Chimera (TBR-065) in Human Medullary Thyroid Cancer: A Preclinical Study;Neuroendocrinology;2020-10-19

5. Emerging drugs for the treatment of acromegaly;Expert Opinion on Emerging Drugs;2020-09-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3